
Investor Connect Sessions
What to expect from this event
The ausbiz Capital team is back with our fifth Investor Connect session, exclusively for the ausbiz community.
These briefings allow you to hear directly from ASX-listed company CEOs and ask your questions.
📅 Date: Tuesday, 19th August, 2025
⏰ Time: 1:00 PM Sydney (AEST)
📍 Location: Virtual
▶️ Duration: Approximately 1.5 hours
Our events are about real connection between ASX-listed companies and investors, so don't forget to submit your questions in the registration form. You're also welcome to post questions during the live event.
Register here to attend - it's free!
COMPANIES PRESENTING
Argenica Therapeutics Limited (ASX:AGN) is developing novel neuroprotective therapeutics to reduce brain damage after stroke and other devastating brain injuries.
Immutep (ASX: IMM) is a late clinical-stage biotechnology company developing novel immunotherapies for cancer and autoimmune diseases. The Company is a pioneer in the understanding and advancement of therapeutics related to Lymphocyte Activation Gene-3 (LAG-3), a cell surface molecule that plays a vital role in regulating the immune system.
Paradigm Biopharmaceuticals (ASX: PAR) is a late-stage drug development company working with world leaders in pharmaceutical product development to approach science from a completely different angle.
Patriot Battery Metals (ASX:PMT) is a hard-rock lithium exploration company focused on advancing its district-scale 100%-owned Shaakichiuwaanaan Property.